GuidelineEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2025
Management of patients with transvalvular right ventricular leads undergoing transcatheter tricuspid valve interventions: a scientific statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC endorsed by the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society and the Canadian Heart Rhythm Society.
Guideline in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Transjugular Leadless Pacing in Massive Biatrial Dilation: A Straight Path to the Heart.JACC. Case reports · 2026Article
- Electrophysiological characterization of the Bachmann bundle region using 3D electroanatomical mapping and peak frequency analysis during pacemaker lead implantation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026Article
- Transcatheter Tricuspid Valve Replacement for His Bundle Pacing Lead-Associated Tricuspid Regurgitation.JACC. Case reports · 2026Article
- Tricuspid Regurgitation After Leadless Pacemaker Implantation: The Role of Atrioventricular Synchrony.Clinical cardiology · 2026Review
- Transcatheter tricuspid valve replacement-a comparison of clinical and procedural outcomes of two different prostheses.Frontiers in cardiovascular medicine · 2026Article
- Cardiac lead perforation: Mechanisms, detection, and therapeutic approaches.Heart rhythm O2 · 2026Review
- [Subcutaneous defibrillator (S-ICD)].Herz · 2025Article
- Choosing Between Tricuspid Repair or Replacement: Decision Algorithms.Structural heart : the journal of the Heart Team · 2025Review
- Massive Tricuspid Regurgitation After Implantable Cardioverter Defibrillator Lead Extraction: A Late Complication From Ghost Material.JACC. Case reports · 2025Article
- Device-lead abnormalities and function after transcatheter tricuspid valve replacement.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025Observational
- Jailed or freed? The lead dilemma in transcatheter tricuspid valve replacement.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025Article
- Managing Bradycardia in Patients After Transcatheter Tricuspid Valve Replacement.Structural heart : the journal of the Heart Team · 2025Review
- Impact of lead placement site on right ventricular function: a comparative echocardiographic analysis of apical versus septal pacing in permanent pacemaker recipients.American journal of cardiovascular disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Up to one-third of patients referred for transcatheter tricuspid valve intervention (TTVI) have a transvalvular pacemaker (PPM) or implantable cardioverter-defibrillator (ICD) lead in place. Both the electrophysiology and interventional cardiology communities have been alerted to the complexity of decision-making in this situation due to potential interactions between the leads and the TTVI material, including the risk of jailing or damage to the leads. This document, commissioned by the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC, reviews the scientific evidence to inform Heart Team discussions on the management of patients with a PPM or ICD who are scheduled for or have undergone TTVI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.